Heartflow (HTFL) CFO Verghese Vikram Sells Shares

What Happened

• Vikram Verghese, Chief Financial Officer of Heartflow, sold a total of 24,345 shares in open-market transactions: 7,579 shares on 2026-09-17 at a weighted avg price of $50.11 (proceeds $379,816) and 16,766 shares on 2026-09-18 at a weighted avg price of $50.75 (proceeds $850,926). Total proceeds were approximately $1,230,742.
• These were sales (not purchases), which are often routine insider liquidity events rather than a direct signal of company prospects.

Key Details

• Transaction dates and prices:
  • 2026-09-17: 7,579 shares @ $50.11 (weighted avg); total ≈ $379,816. (Trades priced $50.00–$50.29; see footnote.)
  • 2026-09-18: 16,766 shares @ $50.75 (weighted avg); total ≈ $850,926. (Trades priced $50.00–$52.11; see footnote.)
• Combined sale: 24,345 shares for ≈ $1.23M.
• Shares owned after the transactions: not specified in the information provided in this summary—see the full Form 4 for post-transaction holdings.
• Footnotes of note:
  • F1: Sales were made under a Rule 10b5-1 trading plan adopted June 4, 2026 (prearranged trading plan).
  • F2/F3: Each line reflects multiple executions; reported prices are weighted averages and the filer can provide per-trade breakdown on request.
• Filing: Form 4 was filed on 2026-09-18 reporting transactions from 2026-09-17 and 09-18; this appears to be timely (no late-filing flag shown).

Context

• 10b5-1 plan: Because the sales were effected under a pre-established 10b5-1 plan, they were likely automatic trades scheduled earlier, which generally reduces the weight of these sales as a real-time signal about management’s view.
• For retail investors: sales by executives can be for many reasons (diversification, tax planning, personal liquidity). Purchases are typically considered more informative about insider confidence than routine sales. For full context and exact post-sale holdings, consult the complete Form 4 filing (Accession 0001464521-26-000149).